Some patients with ovarian cancer seem to have good outcomes after autotransplantation, although several biases may have affected these observations. Phase III trials are needed to compare outcomes after autotransplantation with outcomes after conventional chemotherapy.
Topics:
chemotherapy regimen, hematopoietic stem cells, platinum, transplantation, autologous, transplantation, women, ovarian cancer ...
Ann Intern Med. 2000;133(7):504-515. doi:10.7326/0003-4819-133-7-200010030-00009